Top Banner
JOURNALS & BOOKS IN CANCER RESEARCH 2013 www.iospress.com
12

JOURNALS & BOOKS IN CANCER RESEARCH 2013 · scientists, clinicians and policy makers, the reviews not only discuss recent discoveries, but also reflect on their impact in breast cancer

Oct 14, 2019

Download

Documents

dariahiddleston
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: JOURNALS & BOOKS IN CANCER RESEARCH 2013 · scientists, clinicians and policy makers, the reviews not only discuss recent discoveries, but also reflect on their impact in breast cancer

JOURNALS & BOOKS IN

CANCER

RESEARCH2013

www.iospress.com

Page 2: JOURNALS & BOOKS IN CANCER RESEARCH 2013 · scientists, clinicians and policy makers, the reviews not only discuss recent discoveries, but also reflect on their impact in breast cancer

I O S P R E S S J O U R N A L P R O G R A M

All IOS Press journals are published online and in print

Visit www.iospress.com to:

• Enter your subscription online• Check all subscription options including backfiles• Purchase articles on a pay-per-view basis• Obtain a free electronic sample copy• Scan tables of contents• Set up a journal alert• Find complete Instructions for Authors

Open Library®: Open Access at IOS Press

In addition to publishing work in traditional subscription journals, IOS Press offers the option to publish research with open access, i.e. free to

use, download, circulate and disseminate by everyone, wherever in the world, as long as

proper attribution is given to the author and theoriginal source. The Open Library® option is available to all authors and for all journals

published by IOS Press.

IOS PRESS EBOOKS PROGRAM

www.booksonline.iospress.com

• Place your order online for ebooks or hardcopy books

• Browse tables of contents• Read abstracts and preliminary pages free

of charge• Search by subject or book series• Buy single titles and gain immediate access• Become a member and gain full access to all titles

Follow us on Twitter: @IOSPress_STM

Page 3: JOURNALS & BOOKS IN CANCER RESEARCH 2013 · scientists, clinicians and policy makers, the reviews not only discuss recent discoveries, but also reflect on their impact in breast cancer

JOURNALS

Analytical Cellular Pathologywww.iospress.com/journal/analytical-cellular-pathology

Impact Factor: 0.917*

ISSN 2210-7177 (print) / ISSN 2210-7185 (online)

Analytical Cellular Pathology focuses on the burgeoningapplications of physical techniques to the study of cells,tissues and organs in disease to elucidate pathogenesis andfurther translational research, enhanced diagnosis or prognostication, as well as new and better therapies. Of particular relevance are studies that explore the ways thataberrant biochemical and molecular pathways are transducedinto the physical processes that underlie pathogenesis.

The journal appeals to an audience of pathologists, cellbiologists and biochemists, as well as biomedical engineersby focusing on new applications of the rapidly evolvingarray of technologies. Papers should be based on novelconcepts, novel methodologies or the novel use of existingmethodologies that contribute to the study of pathologicprocesses, rather than methodological details only. Approachesinclude tools such as biomedical photonics, surface resonance phenomena andimpedance tomography, as well as new approaches for ultra-high resolutionmagnetic resonance, multispectral, hyperspectral and vibrational mode analysisand computational biology models. Hypothesis generating and hypothesis-testing observational studies are also welcome.

Editor-in-ChiefStanley Cohen, MD, University of Medicine & Dentistry of New Jersey, New Jersey Medical School, Newark, NJ, USA Email: [email protected]

Coordinating Editor Marion C. Cohen, PhD, SUNY Downstate Medical Center, Brooklyn, NY, USAEmail: [email protected]

Associate Editors Ulysses J. Balis, USA Richard Levenson, USAElaine Bearer, USA Jonathan Reichner, USAHilary Coller, USA Thomas Ried, USAWalter Giaretti, Italy Gordon W. Stamp, United KingdomRonald H. Goldfarb, USA Ronald S. Weinstein, USA

Abstracting & Indexing CoverageAcademic Source Complete, Biochemistry & Biophysics Citation Index, Biological Abstracts, BIOSIS Previews, CAB Abstracts, Chemical AbstractsService (CAS), Current Contents/Clinical Medicine, Current Contents®/ LifeSciences, EBSCO Databases, Elsevier BIOBASE, Embase, Global Health,Journal Citation Reports/Science Edition, MEDLINE, Prous Science Integrity,PubMed, Science Citation Index Expanded (SciSearch®), Science CitationIndex® (*Wos), Scopus, SIIC Data Bases

Instructions for Authorswww.iospress.com/journal/analytical-cellular-pathology/?tab=submission-of-manuscripts

Subscription Information 2013Volume 36 (6 issues)Institutional subscription (online only): US$995 / €715Institutional subscription (print only): US$1079 / €775 (including postage and handling)Institutional subscription (print and online): US$1278 / €918 (including postage and handling)Individual subscription (online only): US$250 / €210

Brief History Analytical CellularPathology waslaunched in 1988,changed its name to Cellular Oncologybetween 2005 and2009 and then in2010, reverted to Analytical CellularPathology: CellularOncology. Since 2011it has continued asAnalytical CellularPathology.

*Journal Impact Factors fromJournal Citation Reports®

Science Edition 2011, publishedby Thomson Reuters ©2012

Page 4: JOURNALS & BOOKS IN CANCER RESEARCH 2013 · scientists, clinicians and policy makers, the reviews not only discuss recent discoveries, but also reflect on their impact in breast cancer

Breast DiseaseAn International Journal

www.iospress.com/journal/breast-disease

ISSN 0888-6008 (print) / ISSN 1558-1551 (online)

The recent expansion of work in the field of breast cancerinevitably will hasten discoveries that will impact patientoutcome. This research, that spans basic science, clinicalmedicine, epidemiology and public policy, poses difficultiesfor investigators. Not only is it necessary to be facile incomprehending ideas from many disciplines, but also, it isimportant to understand the public implications of thesediscoveries.

Breast Disease publishes review issues devoted to in-depth analyses of the scientific and public implications of recent research on a specific problemin breast cancer. Meeting the information needs of scientists, clinicians and policy makers, the reviews not only discuss recent discoveries, but also reflect on their impact in breast cancer research or clinicalmanagement.

Breast Disease now also publishes unsolicited peer-reviewedarticles. Topics can cover basic cellular and molecular biology,epidemiology, genetics, clinical research, imaging and socialand legal issues.

Editor-in-ChiefJeffrey E. Green, MD, Bethesda, MD, USA Email: [email protected]

Founding EditorEdison T. Liu, MD, Executive Director, Genome Institute of Singapore

Abstracting & Indexing CoverageAcademic Source Complete, Cancer Prevention and Control Database,Chemical Abstracts Service (CAS), EBSCO Databases, ElsevierBIOBASE, Embase, Epilepsy Education and Prevention Database, Health Education and Promotion Database, Index Medicus, MEDLINE,Prenatal Smoking Cessation Database, PubMed, Scopus

Instructions for Authorswww.iospress.com/journal/breast-disease/?tab=submission-of-manuscripts

Subscription Information 2013Volume 34 (4 issues)Institutional subscription (online only): US$590 / €420Institutional subscription (print only): US$646 / €460 (including postage and handling)Institutional subscription (print and online): US$764 / €544 (including postage and handling)Individual subscription (online only): US$175 / €150

Page 5: JOURNALS & BOOKS IN CANCER RESEARCH 2013 · scientists, clinicians and policy makers, the reviews not only discuss recent discoveries, but also reflect on their impact in breast cancer

Cancer Biomarkerswww.iospress.com/journal/cancer-biomarkers

Impact Factor: 1.078*

ISSN 1574-0153 (print) / ISSN 1875-8592 (online)

Concentrating on molecular biomarkers in cancer research, Cancer Biomarkers publishes original research findings (and reviews solicited by the Editor-in-Chief) on the identification of markers associated with the disease processes, whether or not they are an integral part of the pathological lesion.The disease markers may include, but are not limitedto, genomic, epigenomic, proteomics, cellular andmorphologic and genetic factors predisposing to thedisease or indicating the occurrence of the disease.Manuscripts on these factors or biomarkers, either in altered forms, abnormal concentrations or with abnormal tissue distribution leading to disease causation, are accepted.

Editor-in-ChiefSudhir Srivastava, PhD, MPH, National Cancer Institute, NIH,Bethesda, MD, USAEmail: [email protected]

Associate EditorsWilliam E. Grizzle, MD, PhDAnna Lokshin, PhDAttila T. Lorincz, PhD Paola Muti, MD Karin D. Rodland, PhDTesshi Yamada, MD, PhD

Abstracting & Indexing CoverageAcademic Source Complete, Biological Abstracts, BIOSIS Previews,CAB Abstracts, Chemical Abstracts Service (CAS), ElsevierBIOBASE, Embase, EMBIO, Journal Citation Reports/Science Edition, MEDLINE, Prous Science Integrity, PubsHub, Science Citation Index Expanded (SciSearch®), Scopus

Instructions for Authorswww.iospress.com/journal/cancer-biomarkers/?tab=submission-of-manuscripts

Subscription Information 2013Volumes 13-14; 12 issuesInstitutional subscription (online only): US$1485 / €1090Institutional subscription (print only): US$1653 / €1210 (including postage and handling)Institutional subscription (print and online): US$1950 / €1428(including postage and handling)Individual subscription (online only): US$300 / €250

*Journal Impact Factors fromJournal Citation Reports®

Science Edition 2011, publishedby Thomson Reuters ©2012

Special Issues 2013Beta-blockers inCancerGuest Editor: Dr. Amal Melhem-Bertrand

Biomarker Discordance inBreast Cancer Guest Editors: Naoto T. Ueno andNaoki Niikura

MiRNAs in Cancer:Non-coding RNAsas Appealing Biomarkers for MalignancyGuest Editor: Pier Jr. Morin

Cancer Biomarkersin Romenia: Realities and PerspectivesGuest Editors: Ioana Berindan Neagoeand Angelo Paradiso

Page 6: JOURNALS & BOOKS IN CANCER RESEARCH 2013 · scientists, clinicians and policy makers, the reviews not only discuss recent discoveries, but also reflect on their impact in breast cancer

Disease Markerswww.iospress.com/journal/disease-markers

Impact Factor: 1.642*

ISSN 0278-0240 (print) / ISSN 1875-8630 (online)

Disease Markers publishes original research findings (and reviews solicited by the Editor-in-Chief) on the identificationof markers associated with the disease processes, whetheror not they are an integral part of the pathological lesion.The disease markers may be a genetic host factor predisposing to the disease or the occurrence of cell-surface markers, enzymes or other components, either in altered forms, abnormal concentrations or withabnormal tissue distribution. This journal is designed toprovide a forum for publications dealing with original observations in this developing field on any aspect of thegeneral topic including:

• Identification of new genetic or non-genetic markers(e.g., cell-surface antigens, serum proteins, intra- andextra-cellular enzymes, cytogenic markers and DNA-sequences)

• Population studies of new and existing markers, designed to elucidate information on their normal distribution as well as that in disease states

• Amplification of knowledge about existing markers • Family studies of markers in disease • New techniques for identification and/or isolation of important marker

molecules • Use of monoclonal antibodies for the definition of molecular structures

associated with disease markers • Identification of disease-associated abnormalities in DNA using

recombinant DNA techniques, gene-cloning and DNA restriction enzyme fragment polymorphisms

• Identification of markers identifying malignantly transformed neoplastic cells

Editor-in-ChiefSudhir Srivastava, PhD, MPH, National Cancer Institute, NIH, Bethesda, MD, USAEmail: [email protected]

Associate EditorMichele Carbone, MD, PhD

Abstracting & Indexing CoverageAcademic Source Complete, Biological Abstracts, BIOSIS Previews, Biotechnology Citation Index®, CAB Abstracts, Chemical Abstracts Service(CAS), CSA Illumina, EBSCO Databases, Elsevier BIOBASE, Embase, EMBIO,Global Health, Index Copernicus, Journal Citation Reports/Science Edition,MEDLINE, Prous Science Integrity, PubMed, Reference Update®, Science Citation Index Expanded (SciSearch®), Scopus

Instructions for Authorswww.iospress.com/journal/disease-markers/?tab=submission-of-manuscripts

Subscription Information 2013Volumes 34-35; 12 issuesInstitutional subscription (online only): US$2150 / €1530Institutional subscription (print only): US$2318 / €1650 (including postage and handling)Institutional subscription (print and online): US$2748 / €1956 (including postage and handling)Individual subscription (online only): US$300 / €250

*Journal Impact Factors fromJournal Citation Reports®

Science Edition 2011, publishedby Thomson Reuters ©2012

Special Issue 2013Glycomics Guest Editor: Pamela Marino

Page 7: JOURNALS & BOOKS IN CANCER RESEARCH 2013 · scientists, clinicians and policy makers, the reviews not only discuss recent discoveries, but also reflect on their impact in breast cancer

Human Antibodieswww.iospress.com/journal/human-antibodies

ISSN 1093-2607 (print) / ISSN 1875-869X (online)

Human Antibodies is an international journal designedto bring together all aspects of human hybridomas andantibody technology under a single, cohesive theme.This includes fundamental research, applied science andclinical applications. Emphasis is on antisera, monoclonal antibodies, fusion partners, EBV transformation, transfections, in vitro immunization,defined antigens, tissue reactivity, scale-up production,chimeric antibodies, autoimmunity, naturalantibodies/immune response, anti-idiotypes and hybridomas secreting interesting growth factors. Immunoregulatory molecules, including T cell hybridomas, are also featured.

Editor-in-ChiefMark C. Glassy, PhD, Integrated Medical Sciences Association Foundation, San Diego, CA, USAEmail: [email protected]

Abstracting & Indexing CoverageAcademic Source Complete, Article@inist, Biological Abstracts, BIOSIS Previews, Cambridge Scientific Abstracts, Chemical AbstractsService (CAS), CSA Illumina, EBSCO Databases, Embase, IndexMedicus, MEDLINE, PubMed, Scopus, SUBIS

Instructions for Authorswww.iospress.com/journal/human-antibodies/?tab=submission-of-manuscripts

Subscription Information 2013Volume 22; 4 issuesInstitutional subscription (online only): US$740 / €545Institutional subscription (print only): US$796 / €585 (including postage and handling)Institutional subscription (print and online): US$944 / €694 (including postage and handling)Individual subscription (online only): US$185 / €155

Special Issue 2013Immune Responsein Cancer PatientsGuest Editor: Rishab Gupta

Page 8: JOURNALS & BOOKS IN CANCER RESEARCH 2013 · scientists, clinicians and policy makers, the reviews not only discuss recent discoveries, but also reflect on their impact in breast cancer

Books

New Approaches to Cell and Tissue Imaging: Pathology at the Crossroads

Editor: Stanley CohenFebruary 2013, approx. 500 pages, hardcover

The evolution of anatomic pathology from a discipline based upon direct observation of visuallight images to whole spectrum multi-modality computer-intensive analysis is entering a phaseof accelerated growth. However, the technologic base is expanding more rapidly than our ability to exploit it for diagnostic and experimental pathology. While the theoretical and practicalunderpinnings of the new technology are complex, the underlying principles are quite simple.Energy interactions with a biological specimen basically only involve four kinds of interactions:absorption, reflection, scatter and secondary emission. This holds true, for example, for both a radio wave perturbing aligned molecular dipoles or UV light shining at a slide. Radiologistshave been quicker than pathologists at exploiting this generalization. The reasons for this maybe found in the pixel level complexity of a microscopic slide as compared to a typical radiologicalimage. The aim in pathology is reconstructing images from the data with resolution goodenough for morphologic analysis at the cellular and tissue level, whereas the aim in radiology is to get enough visualization to identify the lesion or location of a biochemical event. Paradoxically, modern radiology deals with both ends of the spectrum; molecules and organs,while pathologists remain focused (pun intended) on cells and tissue architecture, and studymolecular events in that context.

The purpose of this book is to present some of the promising new image-based and relatedtechnologies for the study of visualization, characterization, and study of abnormal cells andtissues that have evolved over the past few years and to discuss their current and potential applications in experimental pathology and, where feasible, clinical pathologic diagnosis. Justas the flourishing of molecular biology has led to a paradigm shift that has rejuvenated ourfield, the convergence of biomedicine, bioengineering, and sophisticated new tools of mathematical analysis will move us towards a towards a more quantitative and analytic discipline.

The authors, all experts in the field, have described this technology in a manner accessible to an audience consisting of pathologists, cell biologists and biochemists as well as biomedical engineers, using their own research as well as literature review to provide descriptions and examples of the use of this new armamentarium. Inevitably, these approaches as well as new techniques for in situ molecular imaging that are outside the scope of this book, as well as evolving non-invasive radiological procedures for screening and diagnosis will lead to a convergence of pathology and radiology.

Page 9: JOURNALS & BOOKS IN CANCER RESEARCH 2013 · scientists, clinicians and policy makers, the reviews not only discuss recent discoveries, but also reflect on their impact in breast cancer

Translational Pathology of Early Cancer

Editors: S. Srivastava and W.E. GrizzleMarch 2012, 568 pp., hardcoverISBN 978-1-61499-023-9 (print)ISBN 978-1-61499-024-6 (online)Price: US$239 / €156

The visual pathologic features of tumors have alwaysbeen the critical parameters in determining tumor type,however, over the last several decades molecular analysisof tumors has played an increasing role in the diagnosticpathology of tumors. Thus, “molecular pathology” hasgradually emerged as a discipline in pathology whichexploits the use of nucleic acid based techniques.

The purpose of this Handbook is to discuss the principlesand the application of selected existing methods of molecular pathology and its use in the detection of early cancer. It describes the molecular changes thatcharacterize preinvasive neoplastic lesions, moleculartargets for early detection, validation of molecular targets and areas of new diagnostic technology that show promise either for early detection of neoplasias or other medically important uses in cancer prevention and care.The book describes recent advances in proteomics, metabolomics, stem cells research,micro RNA and other posttranslational molecular modifications; all these will serve thepressing needs in the development of the practice of personalized medicine.

The book is divided into three sections that follow a sequence from basic mechanisms oftumor development, through the molecular and biological abnormalities found in commontypes of cancers, to the technologies that are most applicable to detecting these biologicalterations in precancerous lesions. Each chapter discusses the scientific underpinnings of the evolution and progression of tumors in order to enable clinicians and other professionals who manage cancer patients to better understand the disease at the molecular and genetic levels.

Page 10: JOURNALS & BOOKS IN CANCER RESEARCH 2013 · scientists, clinicians and policy makers, the reviews not only discuss recent discoveries, but also reflect on their impact in breast cancer

PUBLISH YOUR RESEARCH RESULTS OR CONFERENCE PROCEEDINGS WITH IOS PRESS

IOS Press welcomes proposals for publishing textbooks, edited volumes, handbooks, conference proceedings, monographs anddissertations.

Proposals can be sent to [email protected], or you can fill inthe form in the Authors’ Corner on www.iospress.com.

Why publish with IOS Press?

High visibility of the publication· Book is submitted to relevant scientific indexes· Inclusion in Google Book Search

Lenient copyright policy· Authors retain copyright to their articles· Manuscript versions may be posted freely on personal websites

Print and online publication· DOI registration for all articles· All book articles available as separately downloadable items· High quality print publication produced in the Netherlands

Clear guidelines for authors and editors· Guidelines can be found through the Authors’ Corner

on www.iospress.com · Author templates for LaTeX or MSWord at author’s choice

Personal approach· Dedicated team of skilled publishing professionals· All books receive individual attention· Flexibility

Worldwide marketing and distribution· Books are available through all major booksellers including

Amazon and Barnes & Noble· Sales offices and representatives on all continents

Permanent archiving is guaranteed through an arrangementwith the Dutch Royal Library

To explore IOS Press books and the Authors’ Corner, visit www.iospress.com.

For ebooks, go to www.booksonline.iospress.com

Page 11: JOURNALS & BOOKS IN CANCER RESEARCH 2013 · scientists, clinicians and policy makers, the reviews not only discuss recent discoveries, but also reflect on their impact in breast cancer

Order Online at www.iospress.com Select the title of your choice and click subscribe now. No shipping costs will be charged.

Yes, I would like to order…� Please send me the following journals: ________________________________________

______________________________________________________________________

______________________________________________________________________

� Please send me the following book: New Approaches to Cell and Tissue Imaging: Pathology at the Crossroads

� Please send me the following book: Translational Pathology of Early Cancer

� Please bill me (postage and handling charges will be added)

� Please charge my credit card: � American Express � Euro/MasterCard � Visa

Card #: __________________________________________________________________________

Security Code: ______________________________________________ Exp. Date: ____________

VAT #: __________________________________________________________________________

Name: __________________________________________________________________________

Address: ________________________________________________________________________

City/State: ____________________________ Zip/Postal Code: ________Country: ____________

Email: ________________________________________Fax: ______________________________

Signature: ______________________________________Date: ____________________________

10/12

Order from your local bookseller or usual supplier.

If you would like to order directly from IOS Press, please use one of the addresses below:

ORDER FORM

IOS Press, Inc.4502 Rachael Manor DriveFairfax, VA 22032USATel: +1 703 323 5600Fax: +1 703 323 [email protected](Books only)

IOS PressNieuwe Hemweg 6B1013 BG AmsterdamThe NetherlandsTel: +31 20 688 3355Fax: +31 20 687 0019Email: [email protected]

IOS Pressc/o Accucoms US, Inc.For North America Sales and Customer Service (Journals only)West Point Commons, Suite 201Lansdale, PA 19446USATel: +1 866 855 8967Fax: +1 215 660 5042Email: [email protected]

Page 12: JOURNALS & BOOKS IN CANCER RESEARCH 2013 · scientists, clinicians and policy makers, the reviews not only discuss recent discoveries, but also reflect on their impact in breast cancer

ABOUT IOS PRESS

For 25 years IOS Press has been serving the scientific community worldwide. IOS Press publishes approximately 120 new books each year and around

100 international journals, covering topics ranging fromcomputer science and mathematics to medicine and

the natural sciences. Many titles are listed in the mostimportant abstracting databases, such as Thomson

Reuters’ Journal Citation Reports, MEDLINE and Scopus.

Headquartered in Amsterdam with satellite offices in the USA, Germany, India and China, IOS Press hasestablished several strategic co-publishing initiatives.Notable acquisitions included Delft University Press in 2005 and Millpress Science Publishers in 2008.

IOS Press journals are available through the highly-regarded MetaPress platform(http://iospress.metapress.com).

www.iospress.com